PMID- 36817494
OWN - NLM
STAT- MEDLINE
DCOM- 20230227
LR  - 20230227
IS  - 2094-7313 (Electronic)
IS  - 2094-7321 (Print)
IS  - 2094-7321 (Linking)
VI  - 13
IP  - 4
DP  - 2022 Oct-Dec
TI  - Prevalence and risk factors for human papillomavirus infection among female sex 
      workers in Hanoi and Ho Chi Minh City, Viet Nam: a cross-sectional study.
PG  - 1-11
LID - 10.5365/wpsar.2022.13.4.894 [doi]
AB  - OBJECTIVE: Female sex workers (FSWs) are at high risk of human papillomavirus 
      (HPV) infections and cervical cancer due to their high number of sexual partners. 
      The objectives of this study were to determine the prevalence of HPV and identify 
      risk factors for high-risk HPV infection among FSWs in Hanoi and Ho Chi Minh City 
      (HCMC), Viet Nam. METHODS: A cross-sectional study was conducted in Hanoi and 
      HCMC between December 2017 and May 2018. We surveyed and screened 699 FSWs aged 
      (3)18 years for HPV infection and abnormal cytology. A multivariable modified Cox 
      regression model was used to determine risk factors for high-risk HPV infection. 
      RESULTS: The overall prevalence of any HPV, high-risk HPV and HPV-16/18 infection 
      in the 699 FSWs was 26.3%, 17.6% and 4.0%, respectively, and were similar in both 
      cities. Multiple infections were identified in 127 participants (69.0%). HPV-52 
      was the most prevalent (7%), followed by HPV-58 (6%). Abnormal cytology was 
      detected in 91 participants (13.0%). FSWs who are divorced (adjusted prevalence 
      ratio [aPR]: 1.96, 95% confidence interval [CI]: 1.01-3.81), widowed (aPR: 3.26, 
      95% CI: 1.49-7.12) or living alone (aPR: 1.85, 95% CI: 1.01-3.39) were associated 
      with a higher prevalence of high-risk HPV infection. DISCUSSION: Almost one in 
      five FSWs in Viet Nam are infected with high-risk HPV. This highlights the 
      importance of prevention strategies such as HPV vaccination and screening in this 
      high-risk group.
CI  - (c) 2022 The authors; licensee World Health Organization.
FAU - Pham, Quang Duy
AU  - Pham QD
AD  - Pasteur Institute of Ho Chi Minh City, Ho Chi Minh City, Viet Nam.
AD  - These authors are joint first authors.
FAU - Prem, Kiesha
AU  - Prem K
AD  - Department of Infectious Disease Epidemiology, London School of Hygiene and 
      Tropical Medicine, London, United Kingdom.
AD  - These authors are joint first authors.
FAU - Le, Tuan Anh
AU  - Le TA
AD  - National Institute of Hygiene and Epidemiology, Hanoi, Viet Nam.
FAU - Van Trang, Nguyen
AU  - Van Trang N
AD  - National Institute of Hygiene and Epidemiology, Hanoi, Viet Nam.
FAU - Jit, Mark
AU  - Jit M
AD  - Department of Infectious Disease Epidemiology, London School of Hygiene and 
      Tropical Medicine, London, United Kingdom.
AD  - School of Public Health, University of Hong Kong, Hong Kong, SAR (China).
AD  - Public Health England, Modelling and Economics Unit, London, United Kingdom.
FAU - Nguyen, Tuan Anh
AU  - Nguyen TA
AD  - National Institute of Hygiene and Epidemiology, Hanoi, Viet Nam.
FAU - Cao, Van
AU  - Cao V
AD  - Pasteur Institute of Ho Chi Minh City, Ho Chi Minh City, Viet Nam.
FAU - Le-Ha, Tam-Duong
AU  - Le-Ha TD
AD  - Pasteur Institute of Ho Chi Minh City, Ho Chi Minh City, Viet Nam.
FAU - Chu, Mai Thi Ngoc
AU  - Chu MTN
AD  - National Institute of Hygiene and Epidemiology, Hanoi, Viet Nam.
FAU - Le, Ly Thi Khanh
AU  - Le LTK
AD  - National Institute of Hygiene and Epidemiology, Hanoi, Viet Nam.
FAU - Toh, Zheng Quan
AU  - Toh ZQ
AD  - New Vaccines, Murdoch Children's Research Institute, Parkville, Victoria, 
      Australia.
AD  - Department of Paediatrics, The University of Melbourne, Parkville, Victoria, 
      Australia.
FAU - Brisson, Marc
AU  - Brisson M
AD  - Centre de recherche du CHU de Quebec-Universite Laval, Quebec, Canada.
AD  - Department of Social and Preventive Medicine, Universite Laval, Quebec, Canada.
FAU - Garland, Suzanne
AU  - Garland S
AD  - Department of Obstetrics and Gynaecology, The University of Melbourne, Parkville, 
      Victoria, Australia.
AD  - Centre for Women's Infectious Diseases Research, The Royal Women's Hospital, 
      Parkville, Australia.
FAU - Murray, Gerald
AU  - Murray G
AD  - Department of Obstetrics and Gynaecology, The University of Melbourne, Parkville, 
      Victoria, Australia.
AD  - Centre for Women's Infectious Diseases Research, The Royal Women's Hospital, 
      Parkville, Australia.
FAU - Bright, Kathryn
AU  - Bright K
AD  - New Vaccines, Murdoch Children's Research Institute, Parkville, Victoria, 
      Australia.
FAU - Dang, Duc Anh
AU  - Dang DA
AD  - National Institute of Hygiene and Epidemiology, Hanoi, Viet Nam.
FAU - Tran, Hau Phuc
AU  - Tran HP
AD  - Pasteur Institute of Ho Chi Minh City, Ho Chi Minh City, Viet Nam.
AD  - These authors are joint last authors.
FAU - Mulholland, Edward Kim
AU  - Mulholland EK
AD  - Department of Infectious Disease Epidemiology, London School of Hygiene and 
      Tropical Medicine, London, United Kingdom.
AD  - New Vaccines, Murdoch Children's Research Institute, Parkville, Victoria, 
      Australia.
AD  - Department of Paediatrics, The University of Melbourne, Parkville, Victoria, 
      Australia.
AD  - These authors are joint last authors.
LA  - eng
PT  - Journal Article
DEP - 20221107
PL  - Philippines
TA  - Western Pac Surveill Response J
JT  - Western Pacific surveillance and response journal : WPSAR
JID - 101558993
RN  - human papillomavirus 52
RN  - human papillomavirus 58
SB  - IM
MH  - Humans
MH  - Female
MH  - *Sex Workers
MH  - Cities
MH  - *Papillomavirus Infections/epidemiology
MH  - Cross-Sectional Studies
MH  - Human Papillomavirus Viruses
MH  - Prevalence
MH  - Vietnam/epidemiology
MH  - Human papillomavirus 16
MH  - Human papillomavirus 18
MH  - Risk Factors
PMC - PMC9912289
COIS- Suzanne M. Garland has received grants through her institution from Merck and has 
      delivered lectures and received speaking fees from MSD for work performed in her 
      personal time. All other authors report no conflicts of interest.
EDAT- 2023/02/24 06:00
MHDA- 2023/03/03 06:00
PMCR- 2022/11/07
CRDT- 2023/02/23 09:36
PHST- 2023/02/23 09:36 [entrez]
PHST- 2023/02/24 06:00 [pubmed]
PHST- 2023/03/03 06:00 [medline]
PHST- 2022/11/07 00:00 [pmc-release]
AID - wpsar-13-894 [pii]
AID - 10.5365/wpsar.2022.13.4.894 [doi]
PST - epublish
SO  - Western Pac Surveill Response J. 2022 Nov 7;13(4):1-11. doi: 
      10.5365/wpsar.2022.13.4.894. eCollection 2022 Oct-Dec.